Guangzhou Medical University Cancer Hospital Conducts Clinical Trial on Dynamic Network Analysis Model for Nasopharyngeal Cancer Patients
Researchers at the Guangzhou Medical University Cancer Hospital in China have initiated a clinical trial to develop a precision intervention system for nasopharyngeal cancer (NPC) patients undergoing radiotherapy. The study aims to establish a nutritional symptom network model using multi-source data and create a tailored response plan to optimize nutritional management measures for NPC patients. The team hopes to leverage smart healthcare technology to achieve individualized and precise management of patients' nutritional symptoms.
Key Takeaways:
- The clinical trial, registered under the Chinese Clinical Trial Registry (ChiCTR), aims to construct a dynamic network analysis model for multisource data related to nutritional symptom complexes in NPC patients undergoing radiotherapy.
- The primary objectives of the study are to clarify the patterns of nutritional symptom changes in NPC radiotherapy patients and develop a precise evidence-based response plan tailored to these patterns.
- The study involves developing an intelligent intervention platform for nutritional symptoms in NPC patients, leveraging the advantages of smart healthcare technology for individualized and precise management.
- The team at Guangzhou Medical University Cancer Hospital is working to improve nutritional outcomes for NPC patients undergoing radiotherapy.
- The study aims to provide important population-based evidence and theoretical basis for improving nutritional outcomes in NPC radiotherapy patients.
Statistics:
- The clinical trial is registered under the Chinese Clinical Trial Registry (ChiCTR) with the registration number ChiCTR2500107011.
- The study type is Interventional, focusing on developing a precision intervention system for NPC patients.
- The study involves multi-source data, including nutritional symptoms and patient information.
- The team aims to optimize nutritional management measures for NPC patients using a tailored response plan.
Sources:
- Chinese Clinical Trial Registry (ChiCTR)
- Guangzhou Medical University Cancer Hospital
- Contify.com (Source: Chinese Clinical Trial Registry, copyright 2017)